Page last updated: 2024-10-24

carbamazepine and Bone Diseases, Developmental

carbamazepine has been researched along with Bone Diseases, Developmental in 2 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.

Research Excerpts

ExcerptRelevanceReference
"Prednisolone treatment alone was not successful."1.33Satoyoshi syndrome: a rare multisystemic disorder requiring systemic and symptomatic treatment. ( Heger, S; Kuester, RM; Sippell, WG; Stephani, U; Volk, R, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, HS1
Wang, SY1
Salter, DM1
Wang, CC1
Chen, SJ1
Fan, HC1
Heger, S1
Kuester, RM1
Volk, R1
Stephani, U1
Sippell, WG1

Other Studies

2 other studies available for carbamazepine and Bone Diseases, Developmental

ArticleYear
The impact of the use of antiepileptic drugs on the growth of children.
    BMC pediatrics, 2013, Dec-19, Volume: 13

    Topics: Adolescent; Anticonvulsants; Body Height; Bone Diseases, Developmental; Calcium; Carbamazepine; Cell

2013
Satoyoshi syndrome: a rare multisystemic disorder requiring systemic and symptomatic treatment.
    Brain & development, 2006, Volume: 28, Issue:5

    Topics: Adult; Bone Diseases, Developmental; Carbamazepine; Drug Therapy, Combination; Endocrine System Dise

2006